macula edema associated with retinal vein occulusion
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Those who received faricimab for retinal vein occlusion with macular edema at the Department of Ophthalmology, Fukui University Hospital and its collaborative research institutes between April 1, 2024 and March 31, 2026
Exclusion criteria
Exclusion criteria: Patients who refused to be enrolled in this study. Patients who were unable to undergo ophthalmologic examination due to cognitive or physical factors. Other cases in which the principal investigator determines that the patient is inappropriate as a research subject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the number of microaneurysms in fluorescein angiography and optical coherence tomography angiography before and after faricimab administration | — |
Countries
Japan
Contacts
university of Fukui Hospital Ophthalmology